Condition

Leukemia Relapse (3)

B Acute Lymphoblastic Leukemia (1)

Chronic Graft-versus-host-disease (1)

Leukemia, Myeloid, Acute (1)

Stem Cell Transplant Complications (1)

Overall Status

Unknown status (2)

Recruiting (1)

Sign in for free

Phase

phase 4 (2)

phase 2/phase 3 (1)

Sponsor

Peking University People's Hospital (1)

University Hospital, Angers (1)

Zhujiang Hospital (1)

Collaborator

First Affiliated Hospital, Sun Yat-Sen University (1)

Nanfang Hospital of Southern Medical University (1)

Second Affiliated Hospital, Sun Yat-Sen University (1)

Intervention

atg (1)

collection of blood samples (1)

decitabine (1)

mbu/cy (1)

mbu/cy and atg (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (3)

Study Type

Interventional (3)

leukemia relapse

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stem Cell Transplant Complications, Leukemia, Myeloid, Acute, Leukemia Relapse Trial in Beijing (Decitabine, mBU/CY and ATG,

Recruiting

Stem Cell Transplant Complications
+2 more

Decitabine
+2 more

Beijing, Beijing, China

Peking University Institute of Hematology,Beijing

Mar 9, 2020

B Acute Lymphoblastic Leukemia, Leukemia Relapse Trial in France (Collection of blood samples)

Unknown status

B Acute Lymphoblastic Leukemia
Leukemia Relapse

Collection of blood samples

Amiens, France
+17 more

Feb 4, 2020

Chronic Graft-versus-host-disease, Leukemia Relapse Trial (ATG)

Unknown status

Chronic Graft-versus-host-disease
Leukemia Relapse

ATG

(no location specified)

Jun 15, 2017